Spyre Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold SYRE, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

29
Funds holding
$1757052184
Total value held
Buying
27 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $577656391 6506605 +985384 +17.85%
2 State Street Corp $271437392 3057416 +450385 +17.28%
3 Bank Of America Corp /De/ $157837878 1777854 +549761 +44.77%
4 Goldman Sachs Group Inc $131222079 1478059 +1208121 +447.55%
5 Franklin Resources Inc $130767861 1472943 +590110 +66.84%
6 Jpmorgan Chase & Co $98870628 1093026 +113727 +11.61%
7 Janus Henderson Group Plc $83586597 1656164 +1656164 NEW BUY
8 Ubs Group Ag $74847843 843071 +843071 NEW BUY
9 Northern Trust Corp $59884685 674529 +95622 +16.52%
10 Morgan Stanley $44386718 499963 +253244 +102.64%
11 Ameriprise Financial Inc $31612960 356082 +356082 NEW BUY
12 Bank Of New York Mellon Corp $21768235 245193 +53798 +28.11%
13 Invesco Ltd. $10701630 120541 +120541 NEW BUY
14 Blackstone Inc. $10669314 120177 +120177 NEW BUY
15 Barclays Plc $8351446 94069 +48283 +105.45%
16 Prudential Financial Inc $7756709 87370 +27815 +46.70%
17 Federated Hermes, Inc. $7630641 85950 +85950 NEW BUY
18 Citigroup Inc $7332606 82593 -17465 -17.45%
19 Wells Fargo & Company/Mn $7324883 82506 +49298 +148.45%
20 Principal Financial Group Inc $5304339 59747 +55448 +1289.79%
21 Raymond James Financial Inc $4761005 53627 +33872 +171.46%
22 Fifth Third Bancorp $1388350 15638 +15633 +312660.00%
23 Sei Investments Co $1237682 13941 +4966 +55.33%
24 Stifel Financial Corp $267316 3011 +3011 NEW BUY
25 Royal Bank Of Canada $208000 2338 -912 -28.06%
26 Us Bancorp \De\ $133791 1507 +1410 +1453.61%
27 Pnc Financial Services Group, Inc. $81145 914 +791 +643.09%
28 Toronto Dominion Bank $23971 270 +270 NEW BUY
29 Zions Bancorporation, National Association /Ut/ $89 1 +1 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.